Med. praxi. 2024;21(5):320-323 | DOI: 10.36290/med.2024.052

Léčba gonartrózy III. stupně u polymorbidní pacientky

MUDr. Helena Zedková
Ambulance praktického lékaře MUDr. Františka Uhlářová, s. r. o., Třinec

Osteoarthritis is a multifactorial disease that affects a large portion of the population. It is reported that the image of osteoarthritis is visible in X-ray examinations in up to 60% of examined individuals over 65. It is one of the most common causes of morbidity. Osteoarthritis accounts for up to 20% of visits to a general practitioner's office. In younger individuals, it can be a cause of disability. It is a multifactorial degenerative joint disease in which there is a disruption in the renewal of joint cartilage. The joint cartilage loses its luster, softens, and fissures form on its surface. Gradually, the cartilage becomes less resilient and losses occur. The subchondral bone becomes sclerotic, and osteophytes form at the edges of the joint. Secondarily, surrounding soft tissues, especially ligaments, are affected. Knee osteoarthritis (gonarthrosis) can affect the medial, lateral femorotibial, or femoropatellar area. It causes pain, typically at the beginning of movement, the pain intensifies and is influenced by the weather. Movement is limited, and axial deformities are often visible. We distinguish four degrees of gonarthrosis based on X-ray findings. Treatment includes regimen measures, pharmacotherapy, and surgical treatment. Analgesics such as nonsteroidal anti-inflammatory drugs (NSAIDs), other non-opioid, and possibly opioid analgesics can be used. The most effective treatment is often with NSAIDs, which suppress the inflammatory component of the process. A suitable representative from the group of analgesics with anti-inflammatory effects is aceclofenac, which preferentially acts on COX-2. It is taken orally, quickly absorbed, and its bioavailability is almost 100%. Aceclofenac is well tolerated and is gentler on the gastrointestinal tract compared to most NSAIDs. The case study illustrates the treatment procedure for a poly morbid patient with gonarthrosis and chronic vertebrogenic algic syndrome of the lumbar spine.

Keywords: osteoarthritis, gonarthrosis, nonsteroidal antiphlogistics.

Accepted: November 20, 2024; Published: December 2, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zedková H. Léčba gonartrózy III. stupně u polymorbidní pacientky. Med. praxi. 2024;21(5):320-323. doi: 10.36290/med.2024.052.
Download citation

References

  1. Horčička V. Osteoartróza. Interní Med. 2004;5:238-243. https://www.internimedicina.cz/pdfs/int/2004/05/03.pdf
  2. Dungl P, et al. Ortopedie, Praha: Grada publishing; 2005: 1280, 991-1012.
  3. Pareek A, Chandanwale AS, Oak J, et al. Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double­‑blind comparative clinical trial versus diclofenac - an Indian experience. Curr Med Res Opin. 2006 May;22(5):977-88. doi: 10.1185/030079906X104722. PMID: 16709320. Go to original source... Go to PubMed...
  4. SPC LP Biofenac
  5. Safety of non­‑steroidal anti­‑anflammatory drugs, SOS final report 2012, www.sos­‑nsaids­‑project.org
  6. Castellsague J, Riera­‑Guardia N, Calingaert B, et al; Safety of Non­‑Steroidal Anti­‑Inflammatory Drugs (SOS) Project. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta­‑analysis of observational studies (the SOS project). Drug Saf. 2012 Dec 1;35(12):1127-46. doi: 10.2165/11633470-000000000-00000. PMID: 23137151; PMCID: PMC3714137. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.